NCT02888171View on ClinicalTrials.gov

Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 12, 2019

Study Completion Date

March 30, 2019

Conditions
Chronic Kidney DiseaseIron DeficiencyAnemia
Interventions
DRUG

ferric citrate

Participants randomized to the ferric citrate arm will take 2 grams of ferric citrate three times a day with meals.

DRUG

ferrous sulfate

Participants randomized to the ferrous sulfate arm will take 325 mg of ferrous sulfate three times a day.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency | Biotech Hunter | Biotech Hunter